Moleculin Biotech Total Assets (Quarterly) Analysis

Moleculin Biotech Inc (MBRX)

4.55 +0.27 (+6.31%) USD | NASDAQ | Apr 18, 16:00

4.55 0.00 (0.00%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	38.22M
September 30, 2023	39.52M
June 30, 2023	47.12M
March 31, 2023	51.06M
December 31, 2022	57.42M
September 30, 2022	65.37M
June 30, 2022	73.26M
March 31, 2022	78.80M
December 31, 2021	84.09M
September 30, 2021	88.70M
June 30, 2021	93.53M
March 31, 2021	99.78M
December 31, 2020	29.03M
September 30, 2020	27.14M
June 30, 2020	31.38M
March 31, 2020	25.47M

Date	Value
December 31, 2019	25.24M
September 30, 2019	30.40M
June 30, 2019	31.85M
March 31, 2019	21.30M
December 31, 2018	19.58M
September 30, 2018	20.90M
June 30, 2018	24.07M
March 31, 2018	24.93M
December 31, 2017	19.48M
September 30, 2017	20.63M
June 30, 2017	21.25M
March 31, 2017	20.32M
December 31, 2016	16.39M
September 30, 2016	17.57M
June 30, 2016	19.23M
March 31, 2016	0.2897M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

25.24M

Minimum

Dec 2019

99.78M

Maximum

Mar 2021

53.55M

Average

47.12M

Median

Jun 2023

Total Assets (Quarterly) Benchmarks

Merck & Co Inc	106.68B
Lixte Biotechnology Holdings Inc	4.309M
Moderna Inc	18.43B
NovaBay Pharmaceuticals Inc	9.034M
Palatin Technologies Inc	13.55M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	12.14M
Shareholders Equity (Quarterly)	26.07M